muramidase has been researched along with Anemia--Aplastic* in 7 studies
1 review(s) available for muramidase and Anemia--Aplastic
Article | Year |
---|---|
Plasma lysozyme--a measure of neutrophil turnover. An analytical review.
Topics: Anemia, Aplastic; Animals; Bacteriological Techniques; Bone Marrow; Glomerular Filtration Rate; Histological Techniques; Humans; Hypersplenism; Immunologic Techniques; Iodine Radioisotopes; Kidney; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Muramidase; Neutrophils; Phosphorus Radioisotopes; Polycythemia Vera; Rabbits | 1974 |
1 trial(s) available for muramidase and Anemia--Aplastic
Article | Year |
---|---|
[Value of lysozyme determination in hematological practice].
Topics: Agranulocytosis; Anemia, Aplastic; Blood Cell Count; Clinical Trials as Topic; Hematologic Diseases; Humans; Leukemia; Leukocytes; Lymphocytes; Methods; Monocytes; Muramidase; Myeloproliferative Disorders | 1974 |
5 other study(ies) available for muramidase and Anemia--Aplastic
Article | Year |
---|---|
[Lysozyme content in the blood as a criterion for the differential diagnosis of pancytopenic states].
Topics: Acute Disease; Adolescent; Adult; Aged; Anemia, Aplastic; Clinical Enzyme Tests; Diagnosis, Differential; Humans; Leukemia; Middle Aged; Muramidase; Pancytopenia | 1978 |
[Studies of lysozyme activity in serum, urine and blood smears from patients with haematological diseases].
Lysozyme activity was studied in blood smears, serum, and urine of patients suffering from leukaemia or other haematological diseases. Increased enzyme activity was found in myelocytic, myelomonocytic and monocytic leukaemia and equally in secondary granulocytosis and polycythaemia vera. Reduced rates were found in lymphocytie leukaemia, malignant lymphoma with bone marrow involvement, and myelophthisic conditions. A rise in urinary lysozyme occurred when the serum level exceeded 50 microgram/ml. Abundant activities were found in myelomonocytic and monocytic leukaemias. Using the bacteriolytic method in blood smears, no enzyme activity was demonstrated in cells of acute or chronic lymphocytic leukaemia, in monocytic leukaemia however, almost all cells show strong reaction. In acute myelocytic or myelomonocytic leukaemia, the portion of positive cells changes from case to case depending on the degree of cell differentiation and maturation. In chronic myelocytic leukaemia there was no difference as compared to enzyme activity of myelocytes in bone marrow of control cases. Thus the bacteriolytic demonstration of lysozyme in blood smears may additionally contribute to distinction of different types of blastic leukaemias, and serum lysozyme also may allow more reliable insight into granulocytic and monocytic myelopoiesis than morphologic studies of blood or bone marrow smears can do, e.g. in agranulocytosis and pancytopenia. Topics: Anemia, Aplastic; Hematologic Diseases; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Muramidase; Waldenstrom Macroglobulinemia | 1977 |
[Serum muramidase assay in patients with refractory anaemia (author's transl)].
Topics: Anemia, Aplastic; Humans; Muramidase | 1976 |
Serum lysozyme and vitamin B 12 binding capacity in myeloproliferative disorders.
Topics: Agranulocytosis; Anemia, Aplastic; Anemia, Macrocytic; Bone Marrow; Chronic Disease; Folic Acid; Humans; Leukemia, Myeloid; Leukocyte Count; Leukocytes; Muramidase; Myeloproliferative Disorders; Neutrophils; Polycythemia Vera; Protein Binding; Vitamin B 12 | 1971 |
Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies.
Topics: Adult; Anemia, Aplastic; Child; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemoid Reaction; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Muramidase; Mycosis Fungoides; Myeloproliferative Disorders; Polycythemia Vera | 1969 |